Merck

Go or no go? August FDA decisions for Axsome, Sanofi and Merck
EP Vantage
Fri, 07/30/21 - 11:04 am
FDA
Axsome Therapeutics
Sanofi
Merck
Pompe disease
depression
kidney cancer
Keytruda
Merck (MRK) Q2 Earnings and Revenues Surpass Estimates
Yahoo/Zacks.com
Fri, 07/30/21 - 11:02 am
Merck
earnings
Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme
BioSpace
Thu, 07/29/21 - 11:08 pm
Merck
Kaiser Permanente
generics
pay-for-delay
Zetia
Vytorin
Merck and Pfizer back a Michigan startup's mission to advance tumor profiling
Endpoints
Thu, 07/29/21 - 11:00 am
Merck
Pfizer
Strata Oncology
DNA sequencing
RNA sequencing
funding
Merck rebounds to win a milestone immunotherapy approval in early breast cancer
BioPharma Dive
Tue, 07/27/21 - 04:39 pm
FDA
Merck
Keytruda
breast cancer
The Fight Continues as Therapies for COVID-19 Race Through Development
BioSpace
Tue, 07/27/21 - 04:22 pm
drug development
COVID-19
Eli Lilly
Merck
Pfizer
Merck women's health spinout Organon bags preterm labor drug ahead of phase 3
Fierce Biotech
Tue, 07/27/21 - 10:33 am
ObsEva
Organon
Merck
preterm labor
ebopiprant
Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer
Endpoints
Thu, 07/22/21 - 10:14 pm
Merck
Keytruda
Lenvima
endometrial cancer
FDA
Kenneth C. Frazier, Merck Executive Chairman and Former CEO, Joins General Catalyst as Chairman of Its Health Assurance Initiatives
Global Newswire
Thu, 07/22/21 - 11:02 am
Ken Frazier
Merck
Pharma CEOs
General Catalyst
venture capital
Mid-Study Peek at Merck's Once-A-Month HIV Preventative Shows Promise
BioSpace
Tue, 07/20/21 - 11:45 pm
Merck
HIV
clinical trials
islatravir
PrEP
Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival
Benzinga
Mon, 07/19/21 - 10:55 am
Merck
vaccines
pneumococcal disease
Vaxneuvance
FDA
Pfizer
Prevnar 13
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Big pharma leads the way in stock market resurgence
EP Vantage
Wed, 07/7/21 - 10:49 am
Big Pharma
pharma stocks
Acadia Pharmaceuticals
AstraZeneca
Biogen
Eli Lilly
GSK
Merck
Moderna Therapeutics
Novartis
Sanofi
Provention Bio
FDA Expands Approval for Keytruda in Locally Advanced Cutaneous SCC
BioSpace
Tue, 07/6/21 - 11:18 pm
Merck
Keytruda
cutaneous squamous cell carcinoma
FDA
Merck to withdraw dangling accelerated approval for Keytruda in third-line stomach cancer
Endpoints
Thu, 07/1/21 - 11:09 pm
Merck
Keytruda
oncology
stomach cancer
FDA
Alpine and Merck Study Checkpoint, Anti-PD-1 Cancer Combo in Collab Study
BioSpace
Wed, 06/30/21 - 09:58 pm
Merck
Alpine Immune Sciences
cancer
ALPN-202
Keytruda
Merck's Keytruda extends life for cervical cancer patients in first-in-class win
Fierce Pharma
Tue, 06/22/21 - 12:29 pm
Merck
Keytruda
cervical cancer
clinical trials
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market
Motley Fool
Thu, 06/17/21 - 10:50 am
Merck
Ridgeback Biotherapeutics
COVID-19
molnupiravir
antivirals
Synthekine nabs megaround in bid to edge out Merck, Sanofi in IL-2 sprint
Endpoints
Thu, 06/10/21 - 10:54 am
Synthekine
Merck
Sanofi

Pages